KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.500 $0.720 Friday, 26th Apr 2024 ADXS stock ended at $0.555. This is 0.91% more than the trading day before Thursday, 25th Apr 2024. During the day the stock fluctuated 0.91% from a day low at $0.550 to a day high of $0.555.
90 days $0.500 $1.49
52 weeks $0.500 $1.95

Historical Advaxis prices

Date Open High Low Close Volume
Feb 14, 2024 $0.683 $0.701 $0.650 $0.680 5 017
Feb 13, 2024 $0.95 $0.95 $0.610 $0.670 110 756
Feb 12, 2024 $1.05 $1.05 $0.770 $0.92 80 165
Feb 09, 2024 $1.14 $1.19 $1.05 $1.15 25 267
Feb 08, 2024 $1.18 $1.18 $1.05 $1.07 30 838
Feb 07, 2024 $1.31 $1.32 $1.09 $1.14 88 960
Feb 06, 2024 $0.92 $1.49 $0.90 $1.31 480 276
Feb 05, 2024 $0.532 $0.590 $0.520 $0.590 16 768
Feb 02, 2024 $0.550 $0.600 $0.549 $0.549 6 341
Feb 01, 2024 $0.550 $0.625 $0.550 $0.580 8 463
Jan 31, 2024 $0.532 $0.555 $0.532 $0.552 5 346
Jan 30, 2024 $0.520 $0.532 $0.520 $0.532 2 597
Jan 29, 2024 $0.600 $0.610 $0.511 $0.520 23 301
Jan 26, 2024 $0.620 $0.639 $0.580 $0.600 2 704
Jan 25, 2024 $0.605 $0.605 $0.560 $0.570 1 109
Jan 24, 2024 $0.571 $0.670 $0.570 $0.600 28 130
Jan 23, 2024 $0.600 $0.620 $0.571 $0.590 8 505
Jan 22, 2024 $0.570 $0.687 $0.570 $0.600 7 163
Jan 19, 2024 $0.570 $0.614 $0.570 $0.614 1 436
Jan 18, 2024 $0.600 $0.601 $0.583 $0.601 3 363
Jan 17, 2024 $0.600 $0.635 $0.600 $0.600 615
Jan 16, 2024 $0.620 $0.680 $0.600 $0.680 41 146
Jan 12, 2024 $0.687 $0.687 $0.570 $0.571 1 486
Jan 11, 2024 $0.600 $0.602 $0.600 $0.600 1 051
Jan 10, 2024 $0.650 $0.650 $0.591 $0.625 1 587
Click to get the best stock tips daily for free!

About Advaxis

Advaxis Advaxis, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of proprietary Listeria monocytogenes (Lm) technology antigen delivery products in the United States. The company is developing ADXS-PSA, which is in Phase 2 clinical trials for the treatment of metastatic prostate cancer; ADXS-503 that is in Phase 1/2 clinical trials for the treatment of non-small cell lung cancer; and ADXS-504 for... ADXS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT